Category: Healthcare and Pharmaceutical

Health Insurance Deal Tombstone

Lucite tombstone marking the acquisition of health services plan Total Care, which operates in four New York counties. The acquirer was Molina Healthcare.

(6ALR522)
1 Image

Lab Beaker-Themed Deal Tombstone

Lab beaker-themed deal tombstone marking the acquisition of Safeware Quasar. Based in Nottingham, England, Safeware Quasar specializes in chemical regulatory compliance software and services.

(6AKLD10)
1 Image

Medical Exam Tombstone

Lucite tombstone marking the acquisition of ExamWorks, an Atlanta-based provider of independent medical exams.

(6ALR454)
1 Image

Lucite Embedment featuring Test Tube

Lucite embedment featuring test tube marking the acquisition of Lodi, Italy-based Euticals. Euticals is focused on custom synthesis and the manufacture of active pharmaceutical ingredients. (6LACC42).  Follow this link to see other examples of Lucite embedments.

1 Image

Implantable Medical Device Tombstone

Lucite tombstone marking equity financing of Minneapolis-based CVRx, a medical device maker.The company produces an implantable device to treat high blood pressure and heart failure.

(6ADL737)
1 Image

Medical Device Developer Tombstone

Lucite tombstone marking the acquisition of Blockade Medical by Balt International. Blockade develops endovascular, catheter-based devices for the treatment of cerebral aneurysms.

(6ALJC03)
1 Image

Custom Lucite with Embedded Pills

Custom Lucite with embedded pills marking the acquisition by Peruvian pharmacy operator Mifarma of Albis Capital.  (6AGP86)

1 Image

Healthcare Provider Deal Toy

Lucite deal toy commemorating the sale by Advent International of its stake in CARE Hospitals, based in Hyderabad, India.

(6LACA37)
1 Image

Pill-Themed Financial Tombstone (Back View)

Back view of pill-themed financial tombstone marking the purchase of New Zealand Pharmaceuticals (NZD). The acquirer was Australian private equity firm Archer Capital.

(6ALR257)
2 Images
Pill-shaped Lucite tombstone commemorating the acquisition of New Zealand Pharmaceuticals by Sydney-based Archer Capital. NZD is a specialty chemicals manufacturer headquartered in Palmerston North.